{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T19:57:29Z","timestamp":1772827049490,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["3\/2\/2\/54-2018 NCD-III"],"award-info":[{"award-number":["3\/2\/2\/54-2018 NCD-III"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["3\/2\/2\/54-2018 NCD-III"],"award-info":[{"award-number":["3\/2\/2\/54-2018 NCD-III"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["3\/2\/2\/54-2018 NCD-III"],"award-info":[{"award-number":["3\/2\/2\/54-2018 NCD-III"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["3\/2\/2\/54-2018 NCD-III"],"award-info":[{"award-number":["3\/2\/2\/54-2018 NCD-III"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["3\/2\/2\/54-2018 NCD-III"],"award-info":[{"award-number":["3\/2\/2\/54-2018 NCD-III"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03006-z","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T13:09:13Z","timestamp":1751375353000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Single nucleotide polymorphism and expression of P16 gene as a potential biomarker for oral and pre-oral cancer"],"prefix":"10.1007","volume":"16","author":[{"given":"Kumud","family":"Nigam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yogendra","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manish Raj","family":"Kulshrestha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aditi","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0983-934X","authenticated-orcid":false,"given":"Somali","family":"Sanyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"3006_CR1","unstructured":"National Cancer Institute [Internet]. Surveillance Epidemiology and End Results: SEER Stat Fact Sheets: Oral Cavity and Pharynx - Available from: http:\/\/www.seer.cancer.gov\/statfacts\/html\/oralcav.html#incidence-mortality. (2013)."},{"key":"3006_CR2","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/sj.bjc.6604999","volume":"100","author":"RD Riley","year":"2009","unstructured":"Riley RD, Sauerbrei W, Altman DG. Prognostic markers in cancer: the evolution of evidence from single studies to metaanalysis, and beyond. Br J Cancer. 2009;100:1219\u201329.","journal-title":"Br J Cancer"},{"key":"3006_CR3","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.oraloncology.2013.12.008","volume":"50","author":"H Polanska","year":"2014","unstructured":"Polanska H, Raudenska M, Gumulec J, et al. Clinical significance of head and neck squamous cell cancer biomarkers. Oral Oncol. 2014;50:168\u201377.","journal-title":"Oral Oncol"},{"issue":"6","key":"3006_CR4","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.ajoms.2020.06.013","volume":"32","author":"DM Ghalwash","year":"2020","unstructured":"Ghalwash DM. Diagnostic and prognostic value of salivary biomarkers in oral cancer and precancer: review Article. J Oral Maxillofac Surg Med Pathol. 2020;32(6):538\u201343.","journal-title":"J Oral Maxillofac Surg Med Pathol"},{"key":"3006_CR5","doi-asserted-by":"crossref","unstructured":"Tanaka T, Ishigamori R. Understanding carcinogenesis for fighting oral cancer. J Oncol. p. 603740 (2011).","DOI":"10.1155\/2011\/603740"},{"key":"3006_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1177\/154405910808700104","volume":"87","author":"S Choi","year":"2008","unstructured":"Choi S, Myers JN. Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy. J Dent Res. 2008;87:14\u201332.","journal-title":"J Dent Res"},{"key":"3006_CR7","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.2217\/fon.12.138","volume":"8","author":"JA Gasche","year":"2012","unstructured":"Gasche JA, Goel A. Epigenetic mechanisms in oral carcinogenesis. Future Oncol. 2012;8:1407\u201325.","journal-title":"Future Oncol"},{"key":"3006_CR8","doi-asserted-by":"crossref","unstructured":"Nigam K, Yadav SK, Samadi FM, Bhatt MLB, Gupta S, Sanyal S. Risk Modulation of Oral Pre Cancer and Cancer with Polymorphisms in XPD and XPG Genes in North Indian Population. APJCP. Aug 1;20(8):2397\u20132403 (2019).","DOI":"10.31557\/APJCP.2019.20.8.2397"},{"key":"3006_CR9","doi-asserted-by":"publisher","first-page":"100513","DOI":"10.1016\/j.oor.2024.100513","volume":"10","author":"CB Thangavel Lakshmipriya, Subash","year":"2024","unstructured":"Thangavel Lakshmipriya, Subash CB, Gopinath. Monitoring changes in the P53 gene mutation to diagnose oral cancer. Oral Oncol Rep. 2024;10:100513.","journal-title":"Oral Oncol Rep"},{"key":"3006_CR10","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1186\/s12903-024-04501-5","volume":"24","author":"SAA Zaidi","year":"2024","unstructured":"Zaidi SAA, Chughtai N, Abbassi ZA, et al. TUSC3, p53 and p21 genetic association with development of oral submucous fibrosis and oral squamous cell carcinoma among addictive tobacco chewers of Pakistan. BMC Oral Health. 2024;24:780.","journal-title":"BMC Oral Health"},{"key":"3006_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1177\/154411130201300106","volume":"13","author":"R Todd","year":"2002","unstructured":"Todd R, Hinds PW, Munger K, et al. Cell cycle dysregulation in oral cancer. Crit Rev Oral Biol Med. 2002;13:51\u201361.","journal-title":"Crit Rev Oral Biol Med"},{"key":"3006_CR12","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/jop.12128","volume":"43","author":"P Nankivell","year":"2014","unstructured":"Nankivell P, Williams H, Webster K, Pearson D, High A, MacLennan K, Senguven B, McConkey C, Rabbitts P, Mehanna H. Investigation of p16(INK4a) as a prognostic biomarker in oral epithelial dysplasia. J Oral Pathol Med. 2014;43:245\u20139.","journal-title":"J Oral Pathol Med"},{"issue":"2","key":"3006_CR13","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3390\/pathogens13020100","volume":"13","author":"D Roberto Gallus","year":"2024","unstructured":"Roberto Gallus D, Rizzo G, Rossi L, Mureddu J, Galli A, Artuso F, Bussu. P16 expression in laryngeal squamous cell carcinoma: A surrogate or independent prognostic marker?? Pathogens. 2024;13(2):100.","journal-title":"Pathogens"},{"key":"3006_CR14","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s12253-018-0542-1","volume":"25","author":"A Abdolamir Allameh","year":"2019","unstructured":"Abdolamir Allameh A, Moazeni-Roodi I, Harirchi M, Ravanshad. Maziar Motiee-Langroudi, Ata garajei, Azin Hamidavi & Seyed Alireza Mesbah-Namin. Promoter DNA methylation and mRNA expression level of p16 gene in oral squamous cell carcinoma: correlation with clinicopathological characteristics. Pathol Oncol Res. 2019;25:1535\u201343.","journal-title":"Pathol Oncol Res"},{"issue":"3","key":"3006_CR15","doi-asserted-by":"publisher","first-page":"376","DOI":"10.4103\/jomfp.jomfp_278_22","volume":"26","author":"S Pallavi","year":"2022","unstructured":"Pallavi S, Sruthi P. Evaluation of p16 expression in oral and oropharyngeal squamous cell carcinoma. J Oral Maxillofacial Pathol. 2022;26(3):376\u201381.","journal-title":"J Oral Maxillofacial Pathol"},{"key":"3006_CR16","doi-asserted-by":"crossref","unstructured":"Baddevithana AK, Jayasinghe RD, Tilakaratne WM, Illeperuma RP, Siriwardena SMS, Bogahawatte. Expression of Human Papillomavirus and the p16 Gene in Oral Potentially Malignant Disorders (OPMD): a Comparative Study With Oral Squamous Cell Carcinoma. Applied Immunohistochemistry & Molecular Morphology. May-Jun;31(5):331\u2013338 (2023).","DOI":"10.1097\/PAI.0000000000001124"},{"issue":"5","key":"3006_CR17","first-page":"965","volume":"90","author":"GD Dimitris Tsakogiannis","year":"2018","unstructured":"Dimitris Tsakogiannis GD, Moschonas E, Bella Z, Kyriakopoulou GD, Amoutzias TG, Dimitriou. Christine kottaridi, Panayotis markoulatos. Association of p16 (CDKN2A) polymorphisms with the development of HPV16-related precancerous lesions and cervical cancer in the Greek population. J Med Oncol. 2018;90(5):965\u201371.","journal-title":"J Med Oncol"},{"key":"3006_CR18","doi-asserted-by":"crossref","unstructured":"Na LYW, Shan K, Xiao-Wei M. C. Shu-Cheng. p16(CDKN2) gene polymorphism: association with histologic subtypes of epithelial ovarian cancer in China. Int J Gynecol Cancer. 18(1) (2008).","DOI":"10.1136\/ijgc-00009577-200801000-00005"},{"key":"3006_CR19","first-page":"88","volume":"17","author":"P Tripathi","year":"2018","unstructured":"Tripathi P, Singh A, Sanyal S, Yadav SK, Nigam K. Association of polymorphism in P16and myeloperoxidase genes with susceptibility to oral lesions in North Indian population. Metagene. 2018;17:88\u201392.","journal-title":"Metagene"},{"issue":"66","key":"3006_CR20","doi-asserted-by":"publisher","first-page":"110635","DOI":"10.18632\/oncotarget.22372","volume":"7","author":"N Deng","year":"2017","unstructured":"Deng N, Zhou H, Fan H, Yuan Y. Single nucleotide polymorphisms and cancer susceptibility. Oncotarget Nov. 2017;7(66):110635\u201349.","journal-title":"Oncotarget Nov"},{"key":"3006_CR21","first-page":"306","volume":"215","author":"A Janice","year":"2016","unstructured":"Janice A, Royds AP, Pilbrow A, Ahn HR, Morrin C, Frampton I, Alasdair Russell CS, Moravec WE, Sweet WH, Wilson Tang, Margaret J, Currie, Noelyn A, Hung, Tania L, Slatter. The rs11515 Polymorphism Is More Frequent and Associated With Aggressive Breast Tumors with Increased ANRIL and Decreased p16INK4aExpression. Frontiers Oncology Jan. 2016;215:306.","journal-title":"Frontiers Oncology Jan"},{"issue":"1","key":"3006_CR22","first-page":"4","volume":"26","author":"Y Yuan","year":"2018","unstructured":"Yuan Y, Joanne B, Weidhaas. Functional MicroRNA binding site variants. Molecular Oncol Dec. 2018;26(1):4\u20138.","journal-title":"Molecular Oncol Dec"},{"issue":"3","key":"3006_CR23","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1266\/ggs.18-00053","volume":"94","author":"A Ranjha Khan","year":"2019","unstructured":"Ranjha Khan A, Aftab S, Tabassum HMJ, Hussain A, Hameed H, Mahmood. Faiza munir, Ihtisham bukhari. Identification of CDKN2A variants in breast cancer patients in Pakistan. Genes Genetic Syst. 2019;94(3):117\u201322.","journal-title":"Genes Genetic Syst"},{"issue":"6","key":"3006_CR24","first-page":"198","volume":"6","author":"S Suguna","year":"2014","unstructured":"Suguna S, Nandal DH, Kamble S, Bharatha A, Kunkulol R. Genomic DNA isolation from human whole blood samples by Non enzymatic salting out method. Int J Pharm Pharm Sci. 2014;6(6):198\u20139.","journal-title":"Int J Pharm Pharm Sci"},{"key":"3006_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/154411130201300106","volume":"13","author":"R Todd","year":"2002","unstructured":"Todd R, Hinds PW. Wong. Cell cycle dysregulation in oral Cancer. Crit Rev Oral Biol Med. 2002;13:1.","journal-title":"Crit Rev Oral Biol Med"},{"key":"3006_CR26","doi-asserted-by":"crossref","unstructured":"Seda Turgut M, Ilhan S, Turan O, Karaman I, Yaylim O, Kucukhuseyin E, Tasan. The Role of p16 and MDM2 Gene Polymorphisms in Prolactinoma: MDM2 Gene Polymorphisms May Be Associated with Tumor Shrinkage. In vivo. May-Jun;31(3):357\u2013363 (2017).","DOI":"10.21873\/invivo.11067"},{"issue":"3","key":"3006_CR27","doi-asserted-by":"publisher","first-page":"40","DOI":"10.14715\/cmb\/2017.63.3.8","volume":"63","author":"Y Dong","year":"2017","unstructured":"Dong Y, Wang X, Yang Y-W, Liu Y-J. The effects of CDKN2A rs3731249, rs11515, and rs3088440 polymorphisms on cancer risk. Cell Mol Biol. 2017;63(3):40.","journal-title":"Cell Mol Biol"},{"key":"3006_CR28","doi-asserted-by":"crossref","unstructured":"Song Y, He S, Zhuang J, Wang G, Ni J, Zhang S, Ye Y, Xia W. MicroRNA-601 serve as a potential tumor suppressor in hepatocellular carcinoma by directly targeting PIK3R3. Mol Med Rep. 2431\u20139 (2019).","DOI":"10.3892\/mmr.2019.9857"},{"issue":"2","key":"3006_CR29","first-page":"102","volume":"28","author":"L Chen","year":"2022","unstructured":"Chen L, Zhu S, Wang H, Pang X, Wang X. MiR-601 promotes cell proliferation of human glioblastoma cells by suppressing TINP1 expression. Altern Ther Health Med. 2022;28(2):102\u20138.","journal-title":"Altern Ther Health Med"},{"key":"3006_CR30","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s11033-011-0752-z","volume":"39","author":"N Thakur","year":"2012","unstructured":"Thakur N, Hussain S, Nasare V, et al. Association analysis of p16 (CDKN2A) and RB1 polymorphisms with susceptibility to cervical cancer in Indian population. Mol Biol Rep. 2012;39:407\u201314.","journal-title":"Mol Biol Rep"},{"key":"3006_CR31","first-page":"640","volume":"11","author":"Y Zheng","year":"2002","unstructured":"Zheng Y, Shen H, Sturgis EM, et al. Haplotypes of two variants in p16 (CDKN2\/MTS-1\/INK4a) exon 3 and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Epidemiol Biomarkers Prev. 2002;11:640\u20135.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"3006_CR32","doi-asserted-by":"crossref","unstructured":"Hongwei Liu X-W, Liu G, Dong J, Zhou Y, Liu Y, Gao X-Y, Liu L, Gu Z. Sun, Dajun DengP16 Methylation as an Early Predictor for Cancer Development From Oral Epithelial Dysplasia: A Double-blind Multicentre Prospective Study. eBio Medicine. Mar 23;2(5):432-7 (2015).","DOI":"10.1016\/j.ebiom.2015.03.015"},{"issue":"4","key":"3006_CR33","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.ijom.2005.08.005","volume":"35","author":"S Y.Nakahara","year":"2006","unstructured":"Y.Nakahara S, Shintani M, Mihara S. Detection of p16 promoter methylation in the serum of oral cancer patients. Int J Oral Maxillofac Surg. 2006;35(4):362\u20135.","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"8","key":"3006_CR34","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1158\/1055-9965.EPI-07-2867","volume":"17","author":"L Gillian","year":"2008","unstructured":"Gillian L, Hall RJ, Shaw E, Anne Field SN, Rogers DN, Sutton JA, Woolgar D, Lowe T, Liloglou JK, Field. Janet M. Risk. p16 promoter methylation is a potential predictor of malignant transformation in oral epithelial dysplasia. Cancer Epidemiol Biomarkers Prev. 2008;17(8):2174\u20139.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"10","key":"3006_CR35","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1038\/modpathol.3800649","volume":"19","author":"T Kyle","year":"2006","unstructured":"Kyle T, Bradley SD, Budnick S, Logani. Immunohistochemical detection of p16INK4a in dysplastic lesions of the oral cavity. Mod Pathol Oct. 2006;19(10):1310\u20136.","journal-title":"Mod Pathol Oct"},{"issue":"5","key":"3006_CR36","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/S1368-8375(99)00020-2","volume":"35","author":"D Akanuma","year":"1999","unstructured":"Akanuma D, Uzawa N, Yoshida MA, Negishi A, Amagasa T, Ikeuchi T. Inactivation patterns of the p16(INK4a) gene in oral squamous cell carcinoma cell lines. Oral Oncol. 1999;35(5):476\u201383.","journal-title":"Oral Oncol"},{"issue":"2","key":"3006_CR37","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jobcr.2019.03.002","volume":"9","author":"M Anshita Agarwal","year":"2019","unstructured":"Anshita Agarwal M, Kamboj B, Shreedhar. Expression of p16 in oral leukoplakia and oral squamous cell carcinoma and correlation of its expression with individual atypical features. J Oral Biology Craniofac Res. 2019;9(2):156\u201360.","journal-title":"J Oral Biology Craniofac Res"},{"issue":"1","key":"3006_CR38","doi-asserted-by":"publisher","first-page":"56","DOI":"10.4103\/jomfp.jomfp_427_23","volume":"15","author":"S Nivethitha Sridharan","year":"2024","unstructured":"Nivethitha Sridharan S, Nagalingam P, Vidhya P, Viswanathan. Prevalence and diagnostic significance of p16, p53 expression in lichen planus as a potential premalignant lesion in oral squamous cell carcinoma. Journal Oral Maxillofacial Pathol Apr. 2024;15(1):56\u201361.","journal-title":"Journal Oral Maxillofacial Pathol Apr"},{"key":"3006_CR39","doi-asserted-by":"crossref","unstructured":"Hitoshi Hirakawa T, Ikegami M, Touyama Y, Ooshiro T, Higa T, Higa S, Agena H, Kinjyo S, Kondo N, Kise. Katsunori Tanaka, Hiroyuki Maeda, Tomoko Tamaki, Naoki Wada, Mikio Suzuki. p16 Overexpression in Sinonasal Squamous Cell Carcinoma: Association with Human Papillomavirus and Prediction of Survival Outcomes. Journal of Clinical Medicine. Oct 30;12(21):6861 (2023).","DOI":"10.3390\/jcm12216861"},{"issue":"8","key":"3006_CR40","first-page":"4049","volume":"17","author":"S Thanun Sritippho","year":"2016","unstructured":"Thanun Sritippho S, Pongsiriwet N, Lertprasertsuke K, Buddhachat T, Sastraruji. Anak lamaroon. p16 - a possible surrogate marker for High-Risk human papillomaviruses in oral cancer?? Asian Pac J Cancer Prev. 2016;17(8):4049\u201357.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"Suppl 1","key":"3006_CR41","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s13193-020-01145-z","volume":"12","author":"VK Agarwal","year":"2021","unstructured":"Agarwal VK, Sharma R, Gahlot G, Amiy Arnav. Clinical and histopathological correlation of p16 and p53 expression in oral Cancer. Indian J Surg Oncol. Apr; 2021;12(Suppl 1):164\u20138.","journal-title":"Indian J Surg Oncol"},{"issue":"5","key":"3006_CR42","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.21873\/anticanres.15719","volume":"42","author":"C Doll","year":"2022","unstructured":"Doll C, Steffen C, Beck-Broichsitter B, Richter M, et al. The prognostic significance of p16 and its role as a surrogate marker for human papilloma virus in oral squamous cell carcinoma: an analysis of 281 cases. Anticancer Res. 2022;42(5):2405\u201313.","journal-title":"Anticancer Res"},{"issue":"1","key":"3006_CR43","doi-asserted-by":"publisher","first-page":"528","DOI":"10.3892\/ol.2021.12789","volume":"22","author":"K-I Norihiko Tokuzen","year":"2021","unstructured":"Norihiko Tokuzen K-I, Nakashiro S, Tojo H, Goda N, Kuribayashi. Daisuke uchida. Human papillomavirus-16 infection and p16 expression in oral squamous cell carcinoma. Oncol Lett. Jul; 2021;22(1):528.","journal-title":"Oncol Lett"},{"key":"3006_CR44","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.oraloncology.2016.03.003","volume":"56","author":"E Mark","year":"2016","unstructured":"Mark E, Zafereo L, Xu KR, Dahlstrom CA, Viamonte AK, Wei G, Li EM. Sturgis. Squamous cell carcinoma of the oral cavity often overexpresses p16 but is rarely driven by human papillomavirus. Oral Oncol. 2016;56:47\u201353.","journal-title":"Oral Oncol"},{"issue":"11","key":"3006_CR45","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.3390\/jpm11111156","volume":"11","author":"H-M Pei-Hung Chang","year":"2021","unstructured":"Pei-Hung Chang H-M, Wang Y-C, Kuo L-Y, Lee C-J, Liao H-C, Kuo C-L, Hsu C-T, Liao, et al. Circulating p16-Positive and p16-Negative tumor cells serve as independent prognostic indicators of survival in patients with head and neck squamous cell carcinomas. J Personalized Med. 2021;11(11):1156.","journal-title":"J Personalized Med"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03006-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03006-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03006-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T01:05:39Z","timestamp":1751418339000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03006-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3006"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03006-z","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"22 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this study was obtained from the Ethical Committee of King George\u2019s Medical University, Lucknow named as Institutional Ethics Committee (Registration No: ECR\/262\/Inst\/UP\/2013) under approval number 85th ECM II B- Ph.D.\/P2. This study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consents (Consent to Participate) were obtained from all participants or, if participants are under 18, from a parent and\/or legal guardian.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Consent to Publish were obtained from all participants or, if participants are under 18, from a parent and\/or legal guardian. All authors have given their consent to publish this work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1229"}}